Patents by Inventor Mira Susa Spring

Mira Susa Spring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Rapamycin and Rapamycin Derivatives for the Treatment of Bone Loss
    Publication number: 20120232011
    Abstract: The present invention relates to a new use of rapamycin and rapamycin derivatives.
    Type: Application
    Filed: May 18, 2012
    Publication date: September 13, 2012
    Inventors: Michaela Kneissel, Mira Susa Spring
  • USE OF RAPAMYCIN AND RAPAMYCIN DERIVATIVES FOR THE TREATMENT OF BONE LOSS
    Publication number: 20090221503
    Abstract: The present invention relates to a new use of rapamycin and rapamycin derivatives.
    Type: Application
    Filed: March 5, 2009
    Publication date: September 3, 2009
    Inventors: Michaela Kneissel, Mira Susa Spring
  • GENE EXPRESSION ASSOCIATED WITH OSTEOBLAST DIFFERENTIATION
    Publication number: 20080118521
    Abstract: The present invention identifies genes whose expression pattern is altered when pre-osteoblastic cells undergo differentiation into mature osteoblasts. The genes identified may be used as markers for the differentiation process. The present invention also provides methods to screen agents that are capable of modulating the differentiation process. The present invention also provides methods of identifying therapeutic agents that stimulate bone formation by analyzing the expression of one or more of the genes identified.
    Type: Application
    Filed: October 25, 2007
    Publication date: May 22, 2008
    Inventors: Mira Susa Spring, Natasa Zamurovic
  • Gene expression associated with osteobla st differentiation
    Publication number: 20070105101
    Abstract: The present invention identifies genes whose expression pattern is altered when pre-osteoblastic cells undergo differentiation into mature osteoblasts. The genes identified may be used as markers for the differentiation process. The present invention also provides methods to screen agents that are capable of modulating the differentiation process. The present invention also provides methods of identifying therapeutic agents that stimulate bone formation by analyzing the expression of one or more of the genes identified.
    Type: Application
    Filed: April 5, 2004
    Publication date: May 10, 2007
    Inventors: Mira Susa Spring, Natasa Zamurovic